Viberzi and Ibuprofen drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Viberzi (eluxadoline) and Ibuprofen (ibuprofen). Common drug interactions include chronic kidney disease among females and anxiety among males.
The phase IV clinical study analyzes what interactions people have when they take Viberzi and Ibuprofen. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.
What is Viberzi?
Viberzi has active ingredients of eluxadoline. eHealthMe is studying from 3,077 Viberzi users. Check the latest studies of Viberzi.
What is Ibuprofen?
Ibuprofen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,270 Ibuprofen users. Check the latest studies of Ibuprofen.
30 people who take Viberzi and Ibuprofen together, and have interactions are studied.

What are the common drug interactions of Viberzi and Ibuprofen, by gender? *:
female:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Anxiety
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal tubular necrosis (death of kidney tubules)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Fatigue (feeling of tiredness)
- Nasopharyngitis (inflammation of the nasopharynx)
- Nausea (feeling of having an urge to vomit)
- Oral fungal infection
male:
- Anxiety
- Hepatic steatosis (fatty liver disease)
- Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
- Hepatosplenomegaly (enlargement of both the liver and the spleen)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Osteoporosis (bones weak and more likely to break)
- Platelet count decreased
- Renal failure (kidney dysfunction)
- Urinary tract infection
- Wrist fracture
What are the common drug interactions of Viberzi and Ibuprofen, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Anxiety
- Chest discomfort
- Decreased appetite
- Dyspnoea (difficult or laboured respiration)
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Peripheral coldness
- Tendonitis (a condition that causes pain and swelling of tendons)
- Tremor (trembling or shaking movements in one or more parts of your body)
- Weight decreased
40-49:
- Anxiety
- Chronic kidney disease
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
- Renal tubular necrosis (death of kidney tubules)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Oral fungal infection
- Oral mucosal erythema (redness of the mucous membrane of mouth)
- Stomatitis (inflammation of mucous membrane of mouth)
- Back injury
50-59:
- Disease progression
- Nausea (feeling of having an urge to vomit)
60+:
- Fatigue (feeling of tiredness)
- Chronic kidney disease
- Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
- Hepatic steatosis (fatty liver disease)
- Hepatosplenomegaly (enlargement of both the liver and the spleen)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Osteoporosis (bones weak and more likely to break)
- Platelet count decreased
- Urinary tract infection
- Wrist fracture
What are the existing conditions these people have? *
- Irritable Bowel Syndrome: 7 people, 23.33%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 20.00%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 16.67%
- Stress And Anxiety: 4 people, 13.33%
- Asthma: 4 people, 13.33%
- Diarrhea: 4 people, 13.33%
- Abdominal Discomfort: 3 people, 10.00%
- Insomnia (sleeplessness): 3 people, 10.00%
- Depression: 3 people, 10.00%
- Sleep Disorder: 3 people, 10.00%
* Approximation only. Some reports may have incomplete information.
Do you take Viberzi and Ibuprofen?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Viberzi and Ibuprofen:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Viberzi:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ibuprofen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Viberzi and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ibuprofen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
- Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
How the study uses the data?
The study uses data from the FDA. It is based on eluxadoline and ibuprofen (the active ingredients of Viberzi and Ibuprofen, respectively), and Viberzi and Ibuprofen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Bupropion Hydrochloride and Cascara - a second ago
- Could Carbamazepine cause Rash Erythematous? - 6 seconds ago
- Drug interactions of Gaviscon and Tagamet Hb - 14 seconds ago
- Could Metronidazole cause Eosinophilic Pneumonia? - 19 seconds ago
- Drug interactions of Pyridostigmine Bromide and Omeprazole - 23 seconds ago
- Could Lanoxin cause Skin Cancer? - 24 seconds ago
- Could Triamcinolone Acetonide cause Hypotension Aggravated? - 25 seconds ago
- Drug interactions of Proair Hfa and Marine Triglyceride - 31 seconds ago
- Could Triamcinolone Acetonide cause Haematocrit Decreased? - 31 seconds ago
- Could Avonex cause Pulmonary Embolism? - 49 seconds ago